Invitae to Present at Upcoming Investor Conferences
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in the following...
Stay updated with breaking news from Jack Finks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in the following...
NVTA earnings call for the period ending March 31, 2022.
Invitae Corporation (NYSE:NYSE:NVTA) Q1 2022 Results Conference Call May 03, 2022 04:30 PM ET Company Participants Jack Finks - IR Sean George - CEO Roxi Wen - CFO Conference Call...
/PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2022 financial...
NVTA earnings call for the period ending December 31, 2021.